XML 148 R133.htm IDEA: XBRL DOCUMENT v3.22.0.1
Quarterly Results of Operations (unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Quarterly Financial Data [Abstract]                      
Total revenue $ 248,358 $ 222,471 $ 222,057 $ 215,071 $ 246,536 $ 239,572 $ 217,299 $ 221,232 $ 907,957 $ 924,639 $ 687,122
Total operating expenses 260,572 229,052 229,728 231,016 246,804 256,020 443,128 246,323 950,368 1,192,275 996,007
Loss from continuing operations 3,053 (13,040) (9,107) (11,190) (10,637) (37,035) (202,013) (78,487) (30,284) (328,172) (307,193)
Income (loss) from discontinued operations, net of tax (8,700) [1] 0 0 1,383 (3,166) (1,135) (1,508) (265) (7,317) [1] (6,074) [1] 1,613 [1]
Net loss attributable to non-controlling interests         822 (822) 0 0 0 0 (3,609)
Net loss attributable to common shareholders of Evolent Health, Inc. - Basic (5,647) (13,040) (9,107) (9,807) (14,625) (37,348) (203,521) (78,752) (37,601) (334,246) (301,971)
Net loss attributable to common shareholders of Evolent Health, Inc. - Diluted $ (5,647) $ (13,040) $ (9,107) $ (9,807) $ (14,625) $ (37,348) $ (203,521) $ (78,752) $ (37,601) $ (334,246) $ (301,971)
Loss per common share                      
Continuing operations, basic (in dollars per share) $ 0.03 $ (0.15) $ (0.11) $ (0.13) $ (0.13) $ (0.43) $ (2.37) $ (0.93) $ (0.35) $ (3.86) $ (3.73)
Continuing operations, diluted (in dollars per share) 0.03 (0.15) (0.11) (0.13) (0.13) (0.43) (2.37) (0.93) (0.35) (3.86) (3.73)
Discontinued operations, basic (in dollars per share) (0.09) 0 0 0.01 (0.04) (0.01) (0.01) 0 (0.09) (0.08) 0.02
Discontinued operations, diluted (in dollars per share) $ (0.09) $ 0 $ 0 $ 0.01 $ (0.04) $ (0.01) $ (0.01) $ 0 $ (0.09) $ (0.08) $ 0.02
[1] Includes $6.8 million loss on disposal of discontinued operations for the year ended December 31, 2021